{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:22:45Z","timestamp":1790508165913,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01731-9","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T08:03:34Z","timestamp":1742025814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improving prostate brachytherapy outcomes through MRI-Assisted dominant lesion dose painting"],"prefix":"10.1186","volume":"25","author":[{"given":"Faranak","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Tahmasebi Birgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mohammadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Feli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-0025","authenticated-orcid":false,"given":"Seyed Masoud","family":"Rezaeijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"issue":"3","key":"1731_CR1","first-page":"28","volume":"8","author":"A Barsouk","year":"2020","unstructured":"Barsouk A, Padala SA, Vakiti A, Mohammed A, Saginala K, Thandra KC, et al. Epidemiology, staging and management of prostate cancer. Med Sci. 2020;8(3):28.","journal-title":"Med Sci"},{"key":"1731_CR2","doi-asserted-by":"crossref","unstructured":"Craig EL, Stopsack KH, Evergren E, Penn LZ, Freedland SJ, Hamilton RJ et al. Statins and prostate cancer\u2014hype or hope? The epidemiological perspective. Prostate Cancer Prostatic Dis. 2022:1\u20139.","DOI":"10.1038\/s41391-022-00554-1"},{"issue":"24","key":"1731_CR3","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan H-J. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317(24):2532\u201342.","journal-title":"JAMA"},{"issue":"22","key":"1731_CR4","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.7314\/APJCP.2014.15.22.9575","volume":"15","author":"M Daniyal","year":"2014","unstructured":"Daniyal M, Siddiqui ZA, Akram M, Asif H, Sultana S, Khan A. Epidemiology, etiology, diagnosis and treatment of prostate cancer. Asian Pac J Cancer Prev. 2014;15(22):9575\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"1731_CR5","doi-asserted-by":"publisher","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harbor Perspect Med. 2018;8(12):a030361.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"4","key":"1731_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2605.2007.00777.x","volume":"30","author":"RH Jack","year":"2007","unstructured":"Jack RH, Davies E, M\u00f8ller H. Testis and prostate cancer incidence in ethnic groups in South East England. Int J Androl. 2007;30(4):215\u201321.","journal-title":"Int J Androl"},{"issue":"3","key":"1731_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","volume":"53","author":"N Cellini","year":"2002","unstructured":"Cellini N, Morganti AG, Mattiucci GC, Valentini V, Leone M, Luzi S, et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiation Oncology* Biology* Phys. 2002;53(3):595\u20139.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"1","key":"1731_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"D De Ruysscher","year":"2019","unstructured":"De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AW, Hegi-Johnson F. Radiotherapy toxicity. Nat Reviews Disease Primers. 2019;5(1):1\u201320.","journal-title":"Nat Reviews Disease Primers"},{"issue":"6","key":"1731_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ejmp.2012.10.002","volume":"29","author":"R Azzeroni","year":"2013","unstructured":"Azzeroni R, Maggio A, Fiorino C, Mangili P, Cozzarini C, De Cobelli F, et al. Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): sensitivity to TCP parameters. Physica Med. 2013;29(6):592\u20138.","journal-title":"Physica Med"},{"issue":"5","key":"1731_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/0284186X.2017.1415457","volume":"57","author":"E Gr\u00f6nlund","year":"2018","unstructured":"Gr\u00f6nlund E, Johansson S, Nyholm T, Thellenberg C, Ahnesj\u00f6 A. Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients. Acta Oncol. 2018;57(5):574\u201381.","journal-title":"Acta Oncol"},{"key":"1731_CR11","first-page":"167","volume-title":"Definition of target volume and organs at risk. Biological target volume","author":"A-L Grosu","year":"2006","unstructured":"Grosu A-L, Sprague LD, Molls M. Definition of target volume and organs at risk. Biological target volume. New Technologies in Radiation Oncology: Springer; 2006. pp. 167\u201377."},{"key":"1731_CR12","doi-asserted-by":"crossref","unstructured":"Kerkmeijer LG, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ et al. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial. 2021.","DOI":"10.1200\/JCO.20.02873"},{"key":"1731_CR13","doi-asserted-by":"crossref","unstructured":"Bentzen SM. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Radiation Oncol Adv. 2008:40\u201361.","DOI":"10.1007\/978-0-387-36744-6_3"},{"issue":"4","key":"1731_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5114\/jcb.2012.32554","volume":"4","author":"C Beskow","year":"2012","unstructured":"Beskow C, \u00c5gren-Cronqvist A-K, Lewensohn R, Toma-Dasu I. Biological effective dose evaluation and assessment of rectal and bladder complications for cervical cancer treated with radiotherapy and surgery. J Contemp Brachytherapy. 2012;4(4):205\u201312.","journal-title":"J Contemp Brachytherapy"},{"key":"1731_CR15","first-page":"4","volume":"10","author":"P Care","year":"2019","unstructured":"Care P. Radiation therapy. Qual Assur. 2019;10:4.","journal-title":"Qual Assur"},{"issue":"1","key":"1731_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-021-01906-2","volume":"16","author":"SM Rezaeijo","year":"2021","unstructured":"Rezaeijo SM, Hashemi B, Mofid B, Bakhshandeh M, Mahdavi A, Hashemi MS. The feasibility of a dose painting procedure to treat prostate cancer based on MpMR images and hierarchical clustering. Radiat Oncol. 2021;16(1):1\u201316.","journal-title":"Radiat Oncol"},{"issue":"3","key":"1731_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.radonc.2011.08.048","volume":"100","author":"G Meijer","year":"2011","unstructured":"Meijer G, Steenhuijsen J, Bal M, De Jaeger K, Schuring D, Theuws J. Dose painting by contours versus dose painting by numbers for stage II\/III lung cancer: practical implications of using a broad or Sharp brush. Radiother Oncol. 2011;100(3):396\u2013401.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1731_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brachy.2018.08.006","volume":"18","author":"A Shaaer","year":"2019","unstructured":"Shaaer A, Davidson M, Semple M, Nicolae A, Mendez LC, Chung H, et al. Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy. Brachytherapy. 2019;18(1):95\u2013102.","journal-title":"Brachytherapy"},{"issue":"3","key":"1731_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2013.04.027","volume":"107","author":"G Bauman","year":"2013","unstructured":"Bauman G, Haider M, Van der Heide UA, M\u00e9nard C. Boosting imaging defined dominant prostatic tumors: a systematic review. Radiother Oncol. 2013;107(3):274\u201381.","journal-title":"Radiother Oncol"},{"key":"1731_CR20","first-page":"44","volume":"12","author":"B Djavan","year":"2005","unstructured":"Djavan B, Milani S, Remzi M. Prostate biopsy: who, how and when. An update. Can J Urol. 2005;12:44\u20138. discussion 99.","journal-title":"Can J Urol"},{"issue":"1","key":"1731_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","volume":"69","author":"D Pucar","year":"2007","unstructured":"Pucar D, Hricak H, Shukla-Dave A, Kuroiwa K, Drobnjak M, Eastham J, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiation Oncology* Biology* Phys. 2007;69(1):62\u20139.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"1","key":"1731_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5114\/jcb.2012.27947","volume":"4","author":"J-M Hannoun-Levi","year":"2012","unstructured":"Hannoun-Levi J-M, Chand-Fouche M-E, Dejean C, Courdi A. Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy. J Contemp Brachytherapy. 2012;4(1):14\u201320.","journal-title":"J Contemp Brachytherapy"},{"issue":"2","key":"1731_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2010.02.014","volume":"95","author":"G Groenendaal","year":"2010","unstructured":"Groenendaal G, van den Berg CA, Korporaal JG, Philippens ME, Luijten PR, van Vulpen M, et al. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol. 2010;95(2):185\u201390.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1731_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.eururo.2019.09.021","volume":"77","author":"RR Engels","year":"2020","unstructured":"Engels RR, Isra\u00ebl B, Padhani AR, Barentsz JO. Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 1: acquisition. Eur Urol. 2020;77(4):457\u201368.","journal-title":"Eur Urol"},{"key":"1731_CR25","doi-asserted-by":"crossref","unstructured":"Manfredi M, Mele F, Garrou D, Walz J, F\u00fctterer JJ, Russo F et al. Multiparametric prostate MRI: technical conduct, standardized report and clinical use. 2018.","DOI":"10.23736\/S0393-2249.17.02846-6"},{"issue":"5","key":"1731_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.brachy.2014.05.006","volume":"13","author":"J Crook","year":"2014","unstructured":"Crook J, Ots A, Gazta\u00f1aga M, Schmid M, Araujo C, Hilts M, et al. Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion. Brachytherapy. 2014;13(5):433\u201341.","journal-title":"Brachytherapy"},{"key":"1731_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.phro.2020.07.005","volume":"15","author":"SW Blake","year":"2020","unstructured":"Blake SW, Stapleton A, Brown A, Curtis S, Ash-Miles J, Dennis E, et al. A study of the clinical, treatment planning and dosimetric feasibility of dose painting in external beam radiotherapy of prostate cancer. Phys Imaging Radiation Oncol. 2020;15:66\u201371.","journal-title":"Phys Imaging Radiation Oncol"},{"issue":"12","key":"1731_CR28","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/0284186X.2018.1512753","volume":"57","author":"T Skj\u00f8tskift","year":"2018","unstructured":"Skj\u00f8tskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, et al. Dose painting for re-irradiation of head and neck cancer. Acta Oncol. 2018;57(12):1693\u20139.","journal-title":"Acta Oncol"},{"issue":"1","key":"1731_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.radonc.2016.02.015","volume":"119","author":"G Ghobadi","year":"2016","unstructured":"Ghobadi G, de Jong J, Hollmann BG, van Triest B, van der Poel HG, Vens C, et al. Histopathology-derived modeling of prostate cancer tumor control probability: implications for the dose to the tumor and the gland. Radiother Oncol. 2016;119(1):97\u2013103.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1731_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.clon.2015.09.006","volume":"28","author":"J Uzan","year":"2016","unstructured":"Uzan J, Nahum A, Syndikus I. Prostate dose-painting radiotherapy and Radiobiological guided optimisation enhances the therapeutic ratio. Clin Oncol. 2016;28(3):165\u201370.","journal-title":"Clin Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01731-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:47:11Z","timestamp":1742068031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01731-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01731-9","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"9 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by ethics committee (IR.AJUMS.MEDICINE.REC.1401.018). All the patients gave written informed consent for their treatment. All experiments were performed in accordance with the guideline approved by the ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and patients\u2019 consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"54"}}